| Abbreviation | Meaning |
| AA | arachidonic acid |
| adrenic acid | cis ω6 polyunsaturated (22:4) or 7,10,13,16-docosatetraenoic acid |
| CHD | coronary heart disease |
| CVD | cardiovascular disease |
| DGLA | dihomo gamma linolenic |
| DHA | docosahexaenoic acid |
| DPA-n6 | docosapentaenoic n-6 acid |
| EPA | eicosapentaenoic acid |
| FA | fatty acid |
| FDR | False Discovery Rate |
| WHS | Women’s Health Study |
| GC | gas chromatography |
| RBC | gas chromatography-mass spectrometry with flame ionization decoupling in red blood cells |
| LC | liquid chromatography |
| LCMS | high-throughput liquid chromatography-mass spectrometry of circulating free FAs, oxylipins and bioactive lipids from plasma |
| plasma PL | LCMS2 plasma phospholipid assay |
| MI | myocardial infarction |
| MS | mass spectrometry |
| n-3 | omega-3 |
| n-6 | omega-6 |
| o3:6i | omega-3 to omega-6 index (=[EPA + DHA]/AA) |
| o3i | omega-3 index (=EPA + DHA) |
| SD | standard deviation |
| VITAL | Vitamin D and Omega-3 Trial |